BB&T Securities LLC raised its holdings in Mazor Robotics Ltd – (NASDAQ:MZOR) by 18.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,858 shares of the medical instruments supplier’s stock after purchasing an additional 2,190 shares during the quarter. BB&T Securities LLC owned 0.05% of Mazor Robotics worth $769,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Wells Fargo & Company MN lifted its position in shares of Mazor Robotics by 7.1% during the 1st quarter. Wells Fargo & Company MN now owns 76,550 shares of the medical instruments supplier’s stock valued at $4,697,000 after buying an additional 5,071 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in shares of Mazor Robotics during the 1st quarter valued at $1,112,000. Private Advisor Group LLC lifted its position in shares of Mazor Robotics by 37.3% during the 1st quarter. Private Advisor Group LLC now owns 8,935 shares of the medical instruments supplier’s stock valued at $548,000 after buying an additional 2,426 shares during the last quarter. First Allied Advisory Services Inc. purchased a new position in shares of Mazor Robotics during the 1st quarter valued at $281,000. Finally, Lord Abbett & CO. LLC purchased a new position in shares of Mazor Robotics during the 1st quarter valued at $2,500,000. Hedge funds and other institutional investors own 23.98% of the company’s stock.
A number of research analysts have recently commented on the company. BidaskClub raised Mazor Robotics from a “buy” rating to a “strong-buy” rating in a research report on Friday. Zacks Investment Research raised Mazor Robotics from a “sell” rating to a “hold” rating in a research report on Friday, September 28th. Needham & Company LLC raised Mazor Robotics from an “underperform” rating to a “hold” rating in a research report on Friday, September 21st. Finally, ValuEngine raised Mazor Robotics from a “hold” rating to a “buy” rating in a report on Friday, September 7th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and two have issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $61.08.
Mazor Robotics (NASDAQ:MZOR) last issued its quarterly earnings data on Thursday, August 2nd. The medical instruments supplier reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.13). Mazor Robotics had a negative return on equity of 7.17% and a negative net margin of 12.80%. The company had revenue of $13.20 million for the quarter, compared to analysts’ expectations of $17.02 million. During the same period last year, the company posted ($0.05) EPS. The business’s revenue for the quarter was down 14.8% on a year-over-year basis. As a group, research analysts predict that Mazor Robotics Ltd – will post -0.12 earnings per share for the current year.
Mazor Robotics Profile
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.
Featured Story: Does the discount rate affect the economy?
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.